Elsevier

Stem Cell Research

Volume 64, October 2022, 102883
Stem Cell Research

Lab Resource: Single Cell Line
Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation

https://doi.org/10.1016/j.scr.2022.102883Get rights and content
Under a Creative Commons license
open access

Abstract

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited cardiovascular disease characterized by left ventricular hypertrophy and cardiomyocyte disarray. In this study, a skin biopsy was obtained from a HCM patient, who carried a missense mutation (c.4384G > A; p.E1462K) in the myosin heavy chain 7 (MYH7) gene. The skin fibroblasts were subsequently reprogrammed with a non-integrated Sendai viral method to generate a patient-specific induced pluripotent stem cell (iPSC) line. The generated iPSC line showed typical morphology and normal karyotype, expressed pluripotency markers, and was capable to differentiate into three germ layers.

Data availability

Data will be made available on request.

Cited by (0)

1

These authors contribute equally.